Results for tag: "Polyangiitis Drug"

Polyangiitis is a rare autoimmune disorder that affects the blood vessels and can cause inflammation of the heart, lungs, and kidneys. It is treated with a combination of drugs, including cardiovascular drugs. These drugs are used to reduce inflammation, improve blood flow, and reduce the risk of organ damage. Common cardiovascular drugs used to treat polyangiitis include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and reduce inflammation. The polyangiitis drug market is a rapidly growing market, driven by the increasing prevalence of the disease and the need for effective treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more